TA-270
Product Specifications
UNSPSC Description
TA-270, a novel quinolinone derivative, is a potent inhibitor of 5-lipoxygenase that plays an important role in asthma research[1].
Target Antigen
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ta-270.html
Smiles
O=C(NC1=CC2=C(C=C1)C(O)=C(OCCCCCCCC)C(N2C)=O)/C=C/C3=CC(OC)=C(O)C(OC)=C3
Molecular Weight
524.61
References & Citations
[1]Y Aoki, et al. Inhibitory effect of a novel quinolinone derivative, TA-270, on asthmatic inflammatory responses in sensitized guinea pigs. Eur J Pharmacol. 2000 Dec 15;409(3):325-30.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-126467/TA-270-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-126467/
Clinical Information
Phase 2
CAS Number
194037-25-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Monoclonal MDM2/HDM2 [p Ser166] Antibody (JE64-20)](https://cdn.genprice.uk/genprice/genprice5.png)
MBS6257279-01 0.1 mL
Papilloma Virus, Human, Type 16, E7 Protein (HPV) (MaxLight 750)
Ask
View Details 
MBS6257279-02 5x 0.1 mL
Papilloma Virus, Human, Type 16, E7 Protein (HPV) (MaxLight 750)
Ask
View Details 